IRIS Accounts Production v24.1.9.2 12978071 director 1.11.22 31.10.23 31.10.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh129780712022-10-31129780712023-10-31129780712022-11-012023-10-31129780712021-10-31129780712021-11-012022-10-31129780712022-10-3112978071ns15:EnglandWales2022-11-012023-10-3112978071ns14:PoundSterling2022-11-012023-10-3112978071ns10:Director12022-11-012023-10-3112978071ns10:PrivateLimitedCompanyLtd2022-11-012023-10-3112978071ns10:Micro-entities2022-11-012023-10-3112978071ns10:AuditExempt-NoAccountantsReport2022-11-012023-10-3112978071ns10:FullAccounts2022-11-012023-10-3112978071ns5:CurrentFinancialInstruments2023-10-3112978071ns5:CurrentFinancialInstruments2022-10-3112978071ns10:RegisteredOffice2022-11-012023-10-31
REGISTERED NUMBER: 12978071 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 October 2023

for

RX Panacea Private Limited

RX Panacea Private Limited (Registered number: 12978071)






Contents of the Financial Statements
for the Year Ended 31 October 2023




Page

Balance Sheet 1


RX Panacea Private Limited (Registered number: 12978071)

Balance Sheet
31 October 2023

31.10.23 31.10.22
£    £    £    £   
FIXED ASSETS 294 314

CURRENT ASSETS 53,912 30,667

CREDITORS
Amounts falling due within one year (8,081 ) (7,313 )
NET CURRENT ASSETS 45,831 23,354
TOTAL ASSETS LESS CURRENT
LIABILITIES

46,125

23,668

CAPITAL AND RESERVES 46,125 23,668

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

RX Panacea Private Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12978071

Registered office: Maghull Business Centre
1 Liverpool Road North
Maghull
Merseyside
L31 2HB

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2022 - 1 ) .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

RX Panacea Private Limited (Registered number: 12978071)

Balance Sheet - continued
31 October 2023


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 4 July 2024 and were signed by:





Dr R Parameswaran - Director